"RNA Splicing Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
RNA-binding proteins that facilitate or inhibit RNA SPLICING.
| Descriptor ID |
D000072260
|
| MeSH Number(s) |
D12.776.157.725.829 D12.776.664.962.829
|
| Concept/Terms |
RNA Splicing Factors- RNA Splicing Factors
- Factors, RNA Splicing
- Splicing Factors, RNA
- Splicing Factors
- Factors, Splicing
|
Below are MeSH descriptors whose meaning is more general than "RNA Splicing Factors".
Below are MeSH descriptors whose meaning is more specific than "RNA Splicing Factors".
This graph shows the total number of publications written about "RNA Splicing Factors" by people in this website by year, and whether "RNA Splicing Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 4 | 4 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 7 | 7 |
| 2016 | 6 | 0 | 6 |
| 2017 | 1 | 4 | 5 |
| 2018 | 5 | 2 | 7 |
| 2019 | 0 | 2 | 2 |
| 2020 | 7 | 1 | 8 |
| 2021 | 3 | 1 | 4 |
| 2022 | 1 | 3 | 4 |
| 2023 | 0 | 7 | 7 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "RNA Splicing Factors" by people in Profiles.
-
COMPREHENSIVE MOLECULAR PROFILING OF UVEAL MELANOMA EVALUATED WITH GENE EXPRESSION PROFILING, PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA EXPRESSION, AND NEXT-GENERATION SEQUENCING. Retina. 2024 09 01; 44(9):1580-1589.
-
RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing. Nat Commun. 2023 Dec 19; 14(1):8444.
-
Long-Read Sequencing Reveals Alternative Splicing-Driven, Shared Immunogenic Neoepitopes Regardless of SF3B1 Status in Uveal Melanoma. Cancer Immunol Res. 2023 12 01; 11(12):1671-1687.
-
Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia. Blood. 2023 11 09; 142(19):1647-1657.
-
Regulation of Postnatal Cardiomyocyte Maturation by an RNA Splicing Regulator RBFox1. Circulation. 2023 10 17; 148(16):1263-1266.
-
Characteristics of patients with myelodysplastic neoplasm and spliceosome mutations. Leukemia. 2023 06; 37(6):1397-1400.
-
Common genetic variations in telomere length genes and lung cancer: a Mendelian randomisation study and its novel application in lung tumour transcriptome. Elife. 2023 04 20; 12.
-
Splicing factor SRSF1 deficiency in the liver triggers NASH-like pathology and cell death. Nat Commun. 2023 02 09; 14(1):551.
-
Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts. Blood Cancer Discov. 2022 11 02; 3(6):554-567.
-
Impact of SF3B1 mutation in myelofibrosis. Leuk Lymphoma. 2022 11; 63(11):2701-2705.